This HTML5 document contains 56 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
n7http://dx.doi.org/10.1007/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n13https://scigraph.springernature.com/pub.10.1007/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q74381020
rdf:type
wikibase:Item
schema:description
im Jahr 1998 veröffentlichter wissenschaftlicher Artikel наукова стаття, опублікована в січні 1998 գիտական հոդված հրատարակված 1998 թվականի հունվարի 1-ին artículu científicu espublizáu en xineru de 1998 artikull shkencor i botuar më 01 janar 1998 wetenschappelijk artikel scientific article published on 01 January 1998 articolo scientifico (pubblicato il 1998)
p:P577
wds:Q74381020-8875F46F-E24A-49AA-B616-7E0788E7E30A
wdt:P577
1998-01-01T00:00:00Z
p:P2888
wds:Q74381020-9174E719-3092-4358-A122-8CE3B29416FA
wdt:P2888
n13:s001130050231
p:P2093
wds:Q74381020-13F7D636-EAD8-436C-9D45-1B75C0062169 wds:Q74381020-6A8D813A-21C7-45D8-9F90-6990C8E6770C wds:Q74381020-6072DDF6-1FB3-46D0-BA68-EC6828BC8665 wds:Q74381020-EE4A7891-CEEB-4019-9E02-D4D1C9ABB87A wds:Q74381020-25BA06ED-6BED-427D-9015-0B3746522619 wds:Q74381020-29A06645-CF1F-4CC2-A7C5-AEFBC1C69321
wdt:P2093
H Gehling R Lefering S Achenbach M Hessmann L Gotzen K Giannadakis
rdfs:label
[Prospective randomized pilot study of ambulatory prevention of thromboembolism. 2 times 500 mg aspirin (ASS) vs. clivarin 1750 (NMH)] [Prospective randomized pilot study of ambulatory prevention of thromboembolism. 2 times 500 mg aspirin [Prospective randomized pilot study of ambulatory prevention of thromboembolism. 2 times 500 mg aspirin (ASS) vs. clivarin 1750 (NMH)]
skos:prefLabel
[Prospective randomized pilot study of ambulatory prevention of thromboembolism. 2 times 500 mg aspirin (ASS) vs. clivarin 1750 (NMH)] [Prospective randomized pilot study of ambulatory prevention of thromboembolism. 2 times 500 mg aspirin [Prospective randomized pilot study of ambulatory prevention of thromboembolism. 2 times 500 mg aspirin (ASS) vs. clivarin 1750 (NMH)]
schema:name
[Prospective randomized pilot study of ambulatory prevention of thromboembolism. 2 times 500 mg aspirin (ASS) vs. clivarin 1750 (NMH)] [Prospective randomized pilot study of ambulatory prevention of thromboembolism. 2 times 500 mg aspirin (ASS) vs. clivarin 1750 (NMH)] [Prospective randomized pilot study of ambulatory prevention of thromboembolism. 2 times 500 mg aspirin
p:P1476
wds:Q74381020-D679A01F-ACE9-47E5-A483-3EFA5AB28EF0
wdt:P1476
[Prospective randomized pilot study of ambulatory prevention of thromboembolism. 2 times 500 mg aspirin (ASS) vs. clivarin 1750 (NMH)]
p:P304
wds:Q74381020-D6B12992-6E24-4C4D-A63F-3B99C73609E5
wdt:P304
42-49
p:P31
wds:Q74381020-5F3F6CDB-5658-4F10-B98D-6A444368A710
wdt:P31
wd:Q13442814
p:P921
wds:Q74381020-E5272BD6-6288-4974-9086-EF11F6021286
wdt:P921
wd:Q18216
p:P698
wds:Q74381020-BA266C97-AB1E-4DB0-ABEA-6ACD7BCF0145
wdtn:P698
n11:9522671
wdt:P698
9522671
p:P1433
wds:Q74381020-A6FCF807-8787-461C-806E-29C8904C21C2
wdt:P1433
wd:Q15753207
p:P433
wds:Q74381020-0939A25B-A2F7-4DF5-90DA-F092E2166316
p:P478
wds:Q74381020-76CF0C97-E5AD-4805-9440-D9BB3ADD0AFF
wdt:P433
1
wdt:P478
101
p:P356
wds:Q74381020-C69E7E60-83A3-4391-BB9A-19DE305E7103
wdtn:P356
n7:S001130050231
wdt:P356
10.1007/S001130050231
p:P6179
wds:Q74381020-9433560F-E153-4750-95F5-382FFA390207
wdt:P6179
1046890214